Publications

2083 Publications

Nov-08

Switching From Premixed Insulin to Insulin Glargine-Based Regimen Improves Glycaemic Control in Patients with Type 1 or Type 2 Diabetes: a Retrospective Primary Care-Based Analysis

Endocrinology Pharmacoepidemiology

Read more

Nov-08

Is Insulin Glargine a Cost Effective Option in Treatment of Patients with Type DM1 with Baseline HBA1C Above 8% in Comparison to NPH and Premix in Poland?

Endocrinology Healthcare Cost Pharmacoepidemiology

Read more

Nov-08

Is Insulin Glargine a Cost-Effective Option for Treatment of Patients Naive to Insulin Treatment with Type 2, Baseline HBA1C Above 8% and Age Below 65 Years in Comparison to NPH and Premix in Poland?

Endocrinology Healthcare Cost Pharmacoepidemiology

Read more

Nov-08

Improved Glycaemic Control by Switching from Insulin NPH to Insulin Glargine: a Retrospective Observational Study

Endocrinology Pharmacoepidemiology

Read more

Nov-08

Cost-Utility of Insulin Glargine Compared to Pre Mix in Type 2 from Public Payer Perspective in Poland

Endocrinology Healthcare Cost Pharmacoepidemiology

Read more

Nov-08

Age threshold for routine aspirin treatment to prevent cardiovascular disease in patients without diabetes

Cardiovascular Pharmacoepidemiology

Read more

Oct-08

Use of Corticosteroids and Corticosteroid-Sparing Agents in the Initial Management of Idiopathic Pulmonary Fibrosis

Pharmacoepidemiology Respiratory

Read more

Sep-08

Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study

Gastroenterology Pharmacoepidemiology

Read more

Sep-08

The incidence rate of seizures in relation to BMI in UK adults

Neurology

Read more

Sep-08

Trends in Survival Following Acute Myocardial Infarction in the United Kingdom: Relation to Changes in Prescribing of Evidence-Based Medication in Primary Care

Cardiovascular Pharmacoepidemiology

Read more

Sep-08

The relative cost effectiveness of insulin glargine versus detemir insulin using UK real life data in patients with type 2 diabetes mellitus

Endocrinology Healthcare Cost Pharmacoepidemiology

Read more

Sep-08

Clinical effectiveness of oral antidiabetic drugs and insulin in the management of type 2 diabetes in UK primary care – a UK population based study

Endocrinology Pharmacoepidemiology

Read more
Date Title Categories Type
Nov-08 Switching From Premixed Insulin to Insulin Glargine-Based Regimen Improves Glycaemic Control in Patients with Type 1 or Type 2 Diabetes: a Retrospective Primary Care-Based Analysis

Endocrinology Pharmacoepidemiology

Abstract
Nov-08 Is Insulin Glargine a Cost Effective Option in Treatment of Patients with Type DM1 with Baseline HBA1C Above 8% in Comparison to NPH and Premix in Poland?

Endocrinology Healthcare Cost Pharmacoepidemiology

Abstract
Nov-08 Is Insulin Glargine a Cost-Effective Option for Treatment of Patients Naive to Insulin Treatment with Type 2, Baseline HBA1C Above 8% and Age Below 65 Years in Comparison to NPH and Premix in Poland?

Endocrinology Healthcare Cost Pharmacoepidemiology

Abstract
Nov-08 Improved Glycaemic Control by Switching from Insulin NPH to Insulin Glargine: a Retrospective Observational Study

Endocrinology Pharmacoepidemiology

Abstract
Nov-08 Cost-Utility of Insulin Glargine Compared to Pre Mix in Type 2 from Public Payer Perspective in Poland

Endocrinology Healthcare Cost Pharmacoepidemiology

Abstract
Nov-08 Age threshold for routine aspirin treatment to prevent cardiovascular disease in patients without diabetes

Cardiovascular Pharmacoepidemiology

Abstract
Oct-08 Use of Corticosteroids and Corticosteroid-Sparing Agents in the Initial Management of Idiopathic Pulmonary Fibrosis

Pharmacoepidemiology Respiratory

Abstract
Sep-08 Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study

Gastroenterology Pharmacoepidemiology

Full Article
Sep-08 The incidence rate of seizures in relation to BMI in UK adults

Neurology

Full Article
Sep-08 Trends in Survival Following Acute Myocardial Infarction in the United Kingdom: Relation to Changes in Prescribing of Evidence-Based Medication in Primary Care

Cardiovascular Pharmacoepidemiology

Abstract
Sep-08 The relative cost effectiveness of insulin glargine versus detemir insulin using UK real life data in patients with type 2 diabetes mellitus

Endocrinology Healthcare Cost Pharmacoepidemiology

Abstract
Sep-08 Clinical effectiveness of oral antidiabetic drugs and insulin in the management of type 2 diabetes in UK primary care – a UK population based study

Endocrinology Pharmacoepidemiology

Abstract
1 162 163 164 165 166 174